Cargando…
BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions
BACE1 initiates the generation of the β-amyloid peptide, which likely causes Alzheimer’s disease (AD) when accumulated abnormally. BACE1 inhibitory drugs are currently being developed to treat AD patients. To mimic BACE1 inhibition in adults, we generated BACE1 conditional knockout (BACE1(fl/fl)) mi...
Autores principales: | Hu, Xiangyou, Das, Brati, Hou, Hailong, He, Wanxia, Yan, Riqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839766/ https://www.ncbi.nlm.nih.gov/pubmed/29444819 http://dx.doi.org/10.1084/jem.20171831 |
Ejemplares similares
-
Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance
por: Singh, Neeraj, et al.
Publicado: (2022) -
BACE1 controls synaptic function through modulating release of synaptic vesicles
por: Das, Brati, et al.
Publicado: (2021) -
BACE1 Deficiency Causes Abnormal Neuronal Clustering in the Dentate Gyrus
por: Hou, Hailong, et al.
Publicado: (2017) -
Role of BACE1 in Alzheimer’s synaptic function
por: Das, Brati, et al.
Publicado: (2017) -
Bace1 Deletion in the Adult Reverses Epileptiform Activity and Sleep–wake Disturbances in AD Mice
por: Yao, Annie Y., et al.
Publicado: (2023)